Literature DB >> 2312900

The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma.

M P Davis1, E M Miller, R C Rau, O E Johnson, R A Naille, M J Crnkovich.   

Abstract

A 70-year-old male with regionally recurrent Merkel cell cancer obtained a complete remission with three cycles of VP16 and cisplatin. His response was consolidated with local radiation therapy. Two additional patients have been reported to have responded to the same combination. Chemotherapy consisting of either cyclophosphamide, vincristine, and doxorubicin or VP16 and cisplatin should be considered in locally recurrent Merkel cell cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2312900     DOI: 10.1111/j.1524-4725.1990.tb03964.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  3 in total

Review 1.  Merkel cell carcinoma of skin: diagnosis and management strategies.

Authors:  Michael Poulsen
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan.

Authors:  A Castagnoli; G Biti; M T De Cristofaro; P Ferri; S M Magrini; M G Papi; S Bianchi
Journal:  Eur J Nucl Med       Date:  1992

3.  Merkel cell carcinoma of the thigh: case report and review of the literature.

Authors:  Wen Jiang; Jiali Xu; Rong Wang; Tingting Wang; Yongqian Shu; Lianke Liu
Journal:  Onco Targets Ther       Date:  2019-01-11       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.